Table 5 The response rate of each drug for patients with an NPSI subscore ≥ 1.

From: Symptom-based pharmacotherapy for neuropathic pain related to spinal disorders: results from a patient-based assessment

 

Pregabalin

Mirogabalin

Duloxetine

Neurotropin

p

Superficial pain

Baseline NPSI subscore

5.2±2.5

5.4±2.8

5.9±2.6

4.2±1.7

0.11

Follow-up NPSI subscore

3.1±2.3

3.6±2.7

4.0±2.6

2.5±1.6

0.27

Response rate (%)

40.4±30.3

38.8±26.7

34.9±26.3

43.7±24.0

0.74

Deep pain

Baseline NPSI subscore

6.6±2.2

5.5±2.0

6.6±2.3

6.1±1.5

0.41

Follow-up NPSI subscore

4.0±2.6

3.3±1.7

4.4±2.6

3.9±1.6

0.66

Response rate (%)

40.9±32.0

39.3±23.2

35.1±29.3

38.1±13.0

0.93

Paroxysmal pain

Baseline NPSI subscore

4.3±2.3

4.5±2.5

4.0±2.3

3.8±2.1

0.75

Follow-up NPSI subscore

2.9±1.9

3.3±2.6

2.8±2.0

2.5±1.9

0.83

Response rate (%)

34.2±29.1

33.8±26.6

35.2±28.4

40.0±17.5

0.86

Evoked pain

Baseline NPSI subscore

3.7±2.7

4.9±2.5

4.1±2.9

3.9±2.2

0.41

Follow-up NPSI subscore

2.7±2.4

3.6±2.5

3.2±2.6

2.6±2.1

0.44

Response rate (%)

32.0±27.1

31.5±25.5

25.1±22.6

38.8±20.8

0.40

Paresthesia/dysesthesia

Baseline NPSI subscore

5.0±2.4

4.9±2.0

5.5±2.6

4.6±2.0

0.67

Follow-up NPSI subscore

3.5±2.3

3.4±2.1

4.0±2.4

2.7±1.8

0.10

Response rate (%)

32.0±27.4

32.5±28.2

26.1±25.0

45.7±19.3

0.013*

Total

Baseline NPSI score

15.0±10.0

15.6±9.6

16.5±9.6

13.8±8.3

0.63

Follow-up NPSI score

10.1±8.2

10.5±7.6

11.7±8.0

8.5±6.4

0.29

Response rate (%)

33.9±27.1

34.6±21.7

30.7±24.8

42.3±18.8

0.091

  1. Data are shown as mean ± SD. Bold, notable results.
  2. NPSI Neuropathic Pain Symptom Inventory.
  3. *p < 0.05.